Who owns Tenax Therapeutics?
- CUSIP Number: 88032l506
Tip: Access positions for across all investors
Analyze quarterly positions in Tenax Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Tenax Therapeutics stock
Who bought or sold Tenax Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
CI Private Wealth | 191k | $52k | 0% | Dec 2023 |
|
Vanguard Group | 186k | $51k | 100% | Dec 2023 |
|
Two Sigma Investments | 142k | $39k | 100% | Dec 2023 |
|
Citadel Advisors | 51k | $14k | 236% | Dec 2023 |
|
Hrt Financial | 21k | $5.0k | 100% | Dec 2023 |
|
Wells Fargo & Company | 184.00 | $51.004800 | 15% | Dec 2023 |
|
Tucker Asset Management | 2.00 | $1.000000 | 0% | Dec 2023 |
|
Who sold out of Tenax Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Two Sigma Securities | Sep 2023 | 97k | $29k |
Virtu Financial | Sep 2023 | 37k | $11k |
Lido Advisors | Sep 2023 | 10k | $3.0k |
Banque Cantonale Vaudoise | Dec 2023 | 50.00 | $0 |